Gopi M Venkatesh

This inventor holds 62 USPTO granted patents and 31 published patent applications, plus 11 CIPO patents and 18 EPO patents, primarily in Pharmaceutical Compositions (CPC class A61K). Top assignees: Adare Pharmaceuticals, Inc., Aptalis Pharmatech, Inc., Ellodi Pharmaceuticals, L.p.. Active years: 2002-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gopi M Venkatesh. Retrieved from https://idiyas.com/inventor/gopi-m-venkatesh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 62 (Patent Applications = 31)

% Patents Active = 59.7

CIPO Patents = 11 (Patent Applications = 3)

EPO Patents = 18 (Patent Applications = 22)

Average Co-Inventor Count = 2.1

ph-index = 16

Forward Citations = 1,139(Granted Patents)

Forward Citations (Not Self Cited) = 723(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Dayton, OH (US) (2002 - 2003)
Lawrenceville, NJ (US) (2021 - 2022)
Vandalia, OH (US) (2006 - 2024)

Company Filing History:

28 out of 30

Adare Pharmaceuticals, Inc.

patents

11 out of 11

Aptalis Pharmatech, Inc.

patents

7 out of 12

Ellodi Pharmaceuticals, L.p.

Eurand Pharmaceuticals, Ltd.

patents

6. 1 out of 1

Adare Pharmaceuticals US, L.p.

8. 1 out of 834,513

Other

patents

Years Active: 2002-2025

Loading Chart...

Areas of Expertise:

Corticosteroid Compositions

Orally Disintegrating Tablets

Drug Delivery Systems

Taste-Masked Formulations

Timed Release Systems

Skeletal Muscle Relaxants

Oral Amphetamine Composition

Solid Solutions

Pulsatile Release Systems

Gastrosoluble Pore-Formers

Modified Release Dosage Forms

Eosinophilic Esophagitis

62 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12447157 - Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis (2025-10-21),

2. 12310976 - Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis (2025-05-27),

3. 12290598 - Orally administered corticosteroid compositions (2025-05-06),

4. 12151028 - Drug delivery systems comprising solid solutions of weakly basic drugs (2024-11-26),

5. 11896562 - Oral amphetamine composition (2024-02-13),

6. 11452689 - Taste-masked pharmaceutical compositions (2022-09-27),

7. 11266598 - Orally administered corticosteroid compositions (2022-03-08),

8. 11260061 - Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis (2022-03-01),

9. 11246828 - Orally administered corticosteroid compositions (2022-02-15),

10. 11166961 - Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis (2021-11-09),

11. 11160772 - Oral amphetamine composition (2021-11-02),

12. 11147772 - Timed, pulsatile release systems (2021-10-19),

13. 10952971 - Taste-masked pharmaceutical compositions with gastrosoluble pore-formers (2021-03-23),

14. 10864166 - Drug delivery systems comprising solid solutions of weakly basic drugs (2020-12-15),

15. 10632069 - Orally administered corticosteroid compositions (2020-04-28),

Title: Gopi M Venkatesh: A Pioneer in Pharmaceutical Innovations

Introduction: Gopi M Venkatesh, based in Vandalia, OH, is a prolific inventor with an impressive portfolio of 58 patents to his name. His work primarily focuses on advancements in pharmaceutical compositions, specifically those aimed at enhancing drug delivery methods.

Latest Patents: Among his most recent innovations is the patent for an oral amphetamine composition. This invention presents a novel formulation that emphasizes taste-masking in various embodiments. One such embodiment includes a highly water-soluble drug like amphetamine, particularly in the form of amphetamine sulfate. Additionally, he has developed taste-masked pharmaceutical compositions, which encompass a method for preparing orally disintegrating tablets. These tablets comprise microparticles of active pharmaceutical ingredients alongside rapidly-dispersing microgranules, thus creating a smooth, easy-to-swallow suspension that disintegrates upon contact with saliva in approximately 60 seconds. Notably, this technology maximizes bioequivalence to reference products, ensuring effective drug delivery.

Career Highlights: Gopi M Venkatesh has contributed significantly to the pharmaceutical industry, specifically through his roles at Adare Pharmaceuticals, Inc. and Aptalis Pharmatech, Inc. His extensive experience in drug formulation and delivery systems has positioned him as a key innovator in this field.

Collaborations: Throughout his career, Gopi has collaborated with accomplished professionals, including James M Clevenger and Jin-Wang Lai. These partnerships have propelled the development of advanced pharmaceutical solutions, emphasizing the importance of teamwork in innovation.

Conclusion: Gopi M Venkatesh remains a prominent figure in pharmaceutical innovations, with a focus on improving oral drug delivery systems. His impressive array of patents showcases his commitment to advancing medical technology and enhancing patient outcomes. As he continues to innovate, the future of pharmaceutical compositions looks promising.

Profile summary based on public USPTO records.